Last reviewed · How we verify

Shanchol vaccine — Competitive Intelligence Brief

Shanchol vaccine (Shanchol vaccine) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Oral inactivated vaccine. Area: Infectious Disease / Immunology.

phase 3 Oral inactivated vaccine Vibrio cholerae O1 and O139 antigens; cholera toxin B subunit Infectious Disease / Immunology Biologic Live · refreshed every 30 min

Target snapshot

Shanchol vaccine (Shanchol vaccine) — International Centre for Diarrhoeal Disease Research, Bangladesh. Shanchol is an oral, inactivated cholera vaccine that stimulates immune responses against Vibrio cholerae O1 and O139 antigens to prevent cholera infection.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Shanchol vaccine TARGET Shanchol vaccine International Centre for Diarrhoeal Disease Research, Bangladesh phase 3 Oral inactivated vaccine Vibrio cholerae O1 and O139 antigens; cholera toxin B subunit

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Oral inactivated vaccine class)

  1. International Centre for Diarrhoeal Disease Research, Bangladesh · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Shanchol vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/shanchol-vaccine. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: